Stocks
107898IDIX
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company focused on developing antiviral therapies for infectious diseases, with a pipeline centered on hepatitis C and other viral infections. Its lead programs have historically targeted polymerase and protease inhibitors, and investors track it for its early-stage drug development potential and partnership opportunities.
Congressional Interest in 107898 (IDIX)
1 member of Congress has disclosed 1 trade in 107898 (IDIX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading IDIX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-04-30 | JOHN K. DELANEY | sell | $15K-$50K |